Eddingpharm to Distribute Breast Cancer Drug for GSK in China

09:38 EDT 9 Apr 2013 | ChinaBio Today

Eddingpharm, a Shanghai company, signed a collaboration agreement with GlaxoSmithKline China that gives Eddingpharm exclusive rights to market and distribute Tykerb in China. Tykerb was recently approved by the SFDA as a treatment for patients with H...

Original Article: Eddingpharm to Distribute Breast Cancer Drug for GSK in China

NEXT ARTICLE

More From BioPortfolio on "Eddingpharm to Distribute Breast Cancer Drug for GSK in China"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement